23.03.2016 • NewsElaine BurridgePrivate EquityBain Capital

Bain Capital Exits IMCD

US private equity firm Bain Capital has sold its remaining 7.9% stake in Netherlands-based specialty chemicals distributor IMCD.

Bain placed 4.2 million shares, priced at €31.25 per share, with institutional investors. The transaction was led by Goldman Sachs International and Deutsche Bank.

Bain used to be IMCD’s main shareholder before the distributor launched an initial public offering (IPO) on the Amsterdam Euronext stock exchange in June 2014. Bain had already reduced its interest from 39.17% to 7.9% by the end of last year.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.